scholarly journals Corynebacterium urealyticum

2020 ◽  
Author(s):  
Keyword(s):  
Corynebacterium Urealyticum

Hyperammonemia in a patient with obstructive urinary tract infection due to Corynebacterium urealyticum

Open Medicine ◽  
2013 ◽  
Vol 8 (5) ◽  
pp. 597-599 ◽  
Author(s):  
Tsuneaki Kenzaka ◽  
Ayako Kumabe ◽  
Yuka Urushibara ◽  
Kensuke Minami ◽  
Takeshi Ishida
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Urine Analysis ◽  
Urine Culture ◽  
Impaired Consciousness ◽  
Rapid Improvement ◽  
Urease Test ◽  
Tract Infections ◽  
Corynebacterium Urealyticum

AbstractA 93-year-old woman with neurogenic bladder was admitted to our hospital because of impaired consciousness. Her urine culture revealed urease-test-positive Corynebacterium urealyticum. She was diagnosed with hyperammonemia due to an obstructive urinary tract infection that was caused by urease-producing bacteria. The patient showed rapid improvement of impaired consciousness and hyperammonemia after urine analysis. It is necessary to consider obstructive urinary tract infection as a differential diagnosis of hyperammonemia, which commonly occurs in urinary tract infections owing to the presence of urease-producing bacteria. Relief from obstruction is the most important treatment for hyperammonemia caused by this mechanism.

Celdoprostatitis incrustante por Corynebacterium urealyticum: la importancia de la sospecha clínica

2018 ◽  
Vol 42 (6) ◽  
pp. 420-421 ◽  
Author(s):  
A. Pardo Martínez ◽  
A. Rosino Sánchez ◽  
Á. Rivero Guerra ◽  
I. Barceló Bayonas
Keyword(s):  
Corynebacterium Urealyticum

In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum).

1986 ◽  
Vol 23 (4) ◽  
pp. 691-694 ◽  
Author(s):  
F Soriano ◽  
C Ponte ◽  
M Santamaría ◽  
C Castilla ◽  
R Fernández Roblas
Keyword(s):  
Stone Formation ◽  
In Vivo Study ◽  
Corynebacterium Urealyticum

scholarly journals Desertomycin G, a New Antibiotic with Activity against Mycobacterium tuberculosis and Human Breast Tumor Cell Lines Produced by Streptomyces althioticus MSM3, Isolated from the Cantabrian Sea Intertidal Macroalgae Ulva sp.

Marine Drugs ◽  
2019 ◽  
Vol 17 (2) ◽  
pp. 114 ◽  
Author(s):  
Alfredo F. Braña ◽  
Aida Sarmiento-Vizcaíno ◽  
Ignacio Pérez-Victoria ◽  
Jesús Martín ◽  
Luis Otero ◽  
...  
Keyword(s):  
Mycobacterium Tuberculosis ◽  
Tumor Cell ◽  
Cell Lines ◽  
Antibiotic Activity ◽  
Breast Adenocarcinoma ◽  
Tumor Cell Lines ◽  
Human Breast ◽  
Antibiotic Resistant ◽  
Clinical Pathogens ◽  
Corynebacterium Urealyticum

The isolation and structural elucidation of a structurally new desertomycin, designated as desertomycin G (1), with strong antibiotic activity against several clinically relevant antibiotic resistant pathogens are described herein. This new natural product was obtained from cultures of the marine actinomycete Streptomyces althioticus MSM3, isolated from samples of the intertidal seaweed Ulva sp. collected in the Cantabrian Sea (Northeast Atlantic Ocean). Particularly interesting is its strong antibiotic activity against Mycobacterium tuberculosis clinical isolates, resistant to antibiotics in clinical use. To the best of our knowledge, this is the first report on a member of the desertomycin family displaying such activity. Additionally, desertomycin G shows strong antibiotic activities against other relevant Gram-positive clinical pathogens such as Corynebacterium urealyticum, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus faecium, Enterococcus faecalis, and Clostridium perfringens. Desertomycin G also displays moderate antibiotic activity against relevant Gram-negative clinical pathogens such as Bacteroides fragilis, Haemophilus influenzae and Neisseria meningitidis. In addition, the compound affects viability of tumor cell lines, such as human breast adenocarcinoma (MCF-7) and colon carcinoma (DLD-1), but not normal mammary fibroblasts.

scholarly journals In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2)

1996 ◽  
Vol 37 (5) ◽  
pp. 1005-1009 ◽  
Author(s):  
J. L. Muñioz-Bellido ◽  
S. Muñioz-Bellido ◽  
J. A. García-Rodrfguez
Keyword(s):  
Vitro Activity ◽  
In Vitro Activity ◽  
Psychiatric Drugs ◽  
Corynebacterium Urealyticum

scholarly journals Complete Genome Sequence of the Type Strain Corynebacterium mustelae DSM 45274, Isolated from Various Tissues of a Male Ferret with Lethal Sepsis

2015 ◽  
Vol 3 (5) ◽  
Author(s):  
Christian Rückert ◽  
Janine Eimer ◽  
Anika Winkler ◽  
Andreas Tauch
Keyword(s):  
Virulence Factors ◽  
Genome Sequence ◽  
Complete Genome Sequence ◽  
Complete Genome ◽  
Type Strain ◽  
Igg Antibodies ◽  
Lethal Sepsis ◽  
Corynebacterium Urealyticum

The complete genome of Corynebacterium mustelae DSM 45274 comprises 3,474,226 bp and 3,188 genes. Prominent niche and virulence factors are SpaBCA- and SpaDEF-type pili with similarity to pilus proteins of Corynebacterium resistens and Corynebacterium urealyticum and an immunomodulatory EndoS-like endoglycosidase probably catalyzing the removal of distinct glycans from IgG antibodies.

Corynebacterium urealyticum: aumento de la incidencia de infección y uropatía incrustante

2016 ◽  
Vol 40 (2) ◽  
pp. 102-107 ◽  
Author(s):  
F.M. Sánchez-Martín ◽  
J.M. López-Martínez ◽  
A. Kanashiro-Azabache ◽  
E. Moncada ◽  
O. Angerri-Feu ◽  
...  
Keyword(s):  
Corynebacterium Urealyticum

scholarly journals Genome informatics and vaccine targets in Corynebacterium urealyticum using two whole genomes, comparative genomics, and reverse vaccinology

BMC Genomics ◽  
2015 ◽  
Vol 16 (Suppl 5) ◽  
pp. S7 ◽  
Author(s):  
Luis Guimarães ◽  
Siomar Soares ◽  
Eva Trost ◽  
Jochen Blom ◽  
Rommel Ramos ◽  
...  
Keyword(s):  
Comparative Genomics ◽  
Reverse Vaccinology ◽  
Whole Genomes ◽  
Corynebacterium Urealyticum ◽  
Genome Informatics
Sign in / Sign up

Export Citation Format

Share Document